Heyy

Hey! How can I help you today?

Make a cheat sheet from these questions since i have no time first give the important ones answers if time permits we'll study remaining Divide them into paper I and 2 btw give answers in text format

Reading File

Running Command

cd /home/daytona/workspace/attachments/733e6aea-b242-4e92-bdea-e62f1ce95eb4/ && python3 -c " import pdfplumber for fname in ['NTRUHS 2K23 MICROBIOLOGY PAPER-1 SUPER-50.pdf', 'NTRUHS 2K23 MICROBIOLOGY PAPER-2 SUPER-50.pdf']: print(f'\n\n========== {fname} ==========') with pdfplumber.open(fname) as pdf: for page in pdf.pages: text = page.extract_text() if text: print(text) "

That's your complete cheat sheet! Here's a quick summary of what's covered:

Paper 1 - 30 topics answered including all ⭐ high-yield ones: HIV/AIDS, Typhoid, Hypersensitivity (all 4 types), Autoimmunity/SLE, Malaria (including cerebral malaria), Hepatitis viruses (all markers), Sterilization/Autoclave, ELISA, Dengue, Drug resistance/MRSA, E. histolytica/Liver abscess, Diarrheagenic E. coli, Leishmaniasis, VZV/Herpes zoster, Cholera, Immunoglobulins, Leprosy, Complement pathways, Giardia, Ascaris, Hookworm, Leptospirosis, Taenia solium, Filariasis, CMI/Immunity types, Dermatophytes, Gas gangrene + more

Paper 2 - 30 topics answered including all ⭐ high-yield ones: TB (all molecular methods), Bacterial/TB/Cryptococcal Meningitis, Syphilis/RPR, Rabies/PEP, Strep pyogenes, Diphtheria/Elek's test, Polio (OPV vs IPV), Influenza/H1N1, Tetanus, Gonorrhea/STIs, Echinococcus, Plague, Aspergillosis, COVID-19, Chlamydia/LGV, Toxoplasma, Atypical pneumonia, Brucellosis, Trichomonas, Pertussis, Naegleria, Slow viruses/Prions, Oncogenic viruses, JE, VHFs, Mumps, Congenital Rubella, Zygomycosis + AETCOM

Topics NOT yet covered (less likely but can do if time permits): Actinomycosis, Campylobacter, Blood culture methods, Enrichment/selective media, Allograft/GVHD, Larva migrans, Toxic shock syndrome, Viral gastroenteritis, Enterobius, H. pylori, Satellite phenomenon, Anaerobic vaginosis, Tularemia, Borrelia vincenti, Paragonimiasis - let me know if you want any of these!

Send the text Again

NTRUHS 2K23 MICROBIOLOGY - CHEAT SHEET

PAPER 1 - HIGH YIELD ANSWERS

⭐ Q1. HIV/AIDS (Q7)

Structure: Enveloped, ss-RNA retrovirus. Icosahedral core.

Structural genes: gag (p24 core), pol (RT, integrase, protease), env (gp120, gp41)
Non-structural genes: tat, rev, nef, vif, vpr, vpu

Pathogenesis: HIV binds CD4 + CCR5/CXCR4 -> enters T-helper cell -> RT makes proviral DNA -> integrates -> replication -> CD4 count falls -> AIDS (<200 cells/µL)

Lab Diagnosis:

ELISA (screening) -> Western Blot (confirmation)
CD4 count, Viral load (PCR)
NACO algorithm: 3 rapid tests (A1, A2, A3)

ART: TDF + 3TC + EFV (first line) PEP: Start within 72 hrs, give for 28 days

Opportunistic fungal infections: Candidiasis (most common), Cryptococcal meningitis, PCP (Pneumocystis jirovecii), Histoplasmosis, Aspergillosis

⭐ Q2. Typhoid Fever (Q6)

Agent: Salmonella typhi (Gram -ve rod) Pathogenesis: Feco-oral -> Peyer's patches -> bacteremia -> rose spots, hepatosplenomegaly

Widal Test:

Positive: O titer ≥1:80, H titer ≥1:160 (single); O ≥1:160 (paired)
O = active infection, H = past infection/vaccination

Lab Diagnosis: Gold standard = Blood culture (1st week), Urine/stool culture (3rd week), Bone marrow culture (most sensitive)

Treatment: Ciprofloxacin / Azithromycin / Ceftriaxone Vaccine: Vi polysaccharide (injectable), Ty21a (oral live attenuated) Drug Resistance: MDR typhoid - resistant to Amp, Chloramphenicol, Co-trimoxazole. XDR - also resistant to fluoroquinolones

⭐ Q3. Hypersensitivity Reactions (Q4)

Type	Name	Mediator	Example
I	Anaphylactic/Immediate	IgE, Mast cells	Anaphylaxis, Asthma, Urticaria
II	Cytotoxic	IgG/IgM + Complement	ABO incompatibility, Autoimmune hemolytic anemia
III	Immune Complex	IgG complexes + Complement	SLE, Serum sickness, Post-strep GN
IV	Delayed (Cell mediated)	T lymphocytes	TB (Mantoux), Contact dermatitis, Graft rejection

Shwartzman Reaction: Two injections of endotoxin (preparatory + provocative) -> local (skin) or generalized (DIC, bilateral cortical necrosis)

⭐ Q4. Autoimmunity + SLE (Q1)

Mechanisms of Autoimmunity:

Molecular mimicry (pathogen resembles self Ag)
Polyclonal B cell activation
Sequestered antigen release
Defective Treg function
Bystander activation

SLE:

ANA - screening test
Anti-dsDNA - specific, correlates with disease activity
Anti-Smith (Anti-Sm) - most specific
Features: Butterfly rash, arthritis, nephritis, serositis, hematologic changes
LE cells seen in peripheral smear

Classification: Organ-specific (Hashimoto's, Type 1 DM, MG) vs Systemic (SLE, RA, Sjogren's)

⭐ Q5. Malaria (Q9)

Plasmodium species: P. falciparum (malignant tertian, most dangerous), P. vivax (benign tertian), P. malariae (quartan), P. ovale

Life Cycle:

Mosquito (Anopheles female): Sexual cycle (sporogony) -> Sporozoites
Human: Liver (exo-erythrocytic) -> RBC (erythrocytic) -> Trophozoite -> Schizont -> Merozoites

Pathogenesis: Rupture of RBCs -> fever, chills. P. falciparum - cytoadherence, rosetting -> cerebral malaria

Lab Diagnosis:

Peripheral smear (Giemsa stain) - Gold standard
RDT - HRP2 antigen for P. falciparum
PCR

Cerebral Malaria: P. falciparum only. Parasitized RBCs block cerebral capillaries. Features: Coma, seizures, mortality ~20%

Treatment: Chloroquine (sensitive), ACT - Artemether+Lumefantrine (falciparum), Primaquine (for P. vivax hypnozoites)

Vaccine: RTS,S (Mosquirix) - first approved malaria vaccine

⭐ Q6. Hepatitis Viruses (Q17)

Virus	Type	Transmission	Chronicity	Markers
HAV	RNA	Feco-oral	No	Anti-HAV IgM (acute)
HBV	DNA	Blood/sexual/vertical	Yes (5-10%)	HBsAg, HBeAg, Anti-HBc IgM
HCV	RNA	Blood	Yes (80%)	Anti-HCV, PCR
HDV	RNA (incomplete)	Blood (needs HBV)	Yes	Anti-HDV
HEV	RNA	Feco-oral	No	Anti-HEV IgM

HBV Markers:

HBsAg: First to appear, marker of infection
HBeAg: Active replication, high infectivity
Anti-HBs: Immunity (natural or vaccine)
Anti-HBc IgM: Acute infection
Window period: HBsAg gone, Anti-HBs not yet - only Anti-HBc IgM present

Prophylaxis HBV: Vaccine (3 doses: 0, 1, 6 months) + HBIG for post-exposure

⭐ Q7. Sterilization & Disinfection (Q5)

Sterilization: Complete destruction of ALL microorganisms including spores.

Moist Heat (most reliable):

Autoclave: 121°C, 15 psi, 15 min (kills spores)
Pasteurization: 62°C/30 min (LTLT) or 72°C/15 sec (HTST)
Boiling: 100°C, 20 min (NOT sterilization - doesn't kill spores)

Dry Heat:

Hot air oven: 160°C/60 min, 170°C/30 min, 180°C/10 min

High Level Disinfectants: Glutaraldehyde 2% (Cidex), Hydrogen peroxide 6%, Formaldehyde, OPA (Ortho-phthalaldehyde)

Gaseous Disinfectants: Ethylene oxide (ETO) - heat-sensitive items; Formaldehyde vapor

Chemical Disinfectants: Phenol (carbolic acid, first antiseptic), Alcohol 70%, Chlorine compounds (hypochlorite), Povidone-iodine

⭐ Q8. ELISA (Q3)

Principle: Antigen-antibody reaction detected by enzyme-linked antibody producing color change.

Types:

Direct ELISA - detect antigen
Indirect ELISA - detect antibody (most common in serology)
Sandwich ELISA - most sensitive, detect antigen
Competitive ELISA

Enzymes used: HRP (Horseradish peroxidase), Alkaline phosphatase

Uses: HIV screening, HBsAg, Dengue NS1, TORCH screening

⭐ Q9. Dengue (Q8)

Agent: Flavivirus, ss RNA, 4 serotypes (DEN 1-4), Aedes aegypti mosquito

Pathogenesis: Secondary infection with different serotype -> Antibody-Dependent Enhancement (ADE) -> more severe disease (DHF/DSS)

Clinical Features: High fever, retro-orbital pain, myalgia, rash, thrombocytopenia, hemorrhage

Lab Diagnosis:

NS1 antigen (day 1-5) - early marker
IgM (from day 5 onwards)
IgG (secondary infection marker)
PCR - most sensitive early

Tourniquet Test (Rumpel-Leede): Positive = >20 petechiae per sq inch

⭐ Q10. Agglutination Reactions + Monoclonal Antibodies (Q2)

Agglutination: Clumping of particulate antigens by antibodies.

Direct: Widal, ABO blood grouping, Cold agglutinins (Mycoplasma)
Indirect (passive): Latex agglutination (CRP, RF, Cryptococcal Ag)
Coombs test: Direct (sensitized RBCs) vs Indirect (detect IgG antibodies in serum)

Monoclonal Antibodies: Produced by hybridoma technology (B cell + myeloma cell = hybridoma)

Uses: Diagnostic (pregnancy tests, tumor markers) and Therapeutic (Infliximab, Rituximab, Trastuzumab)

⭐ Q11. Drug Resistance in Bacteria (Q21)

Genetic Mechanisms:

Chromosomal mutation (spontaneous)
Plasmid/R-factor mediated (most common clinically)
Transposons (jumping genes)
Transfer by: Conjugation (main route), Transformation, Transduction

Mechanisms of Resistance:

Enzyme inactivation - beta-lactamase destroys penicillin
Altered target site - MRSA (altered PBP2a)
Efflux pumps
Reduced permeability (porin channel changes)
Bypass pathway

MRSA: mecA gene encodes PBP2a (low affinity for all beta-lactams). Treatment: Vancomycin / Linezolid

⭐ Q12. Entamoeba histolytica (Q12)

Agent: Trophozoite (10-60 µm, ingested RBCs - pathognomonic) and cyst (4 nuclei) Transmission: Feco-oral

Pathogenesis: Cyst ingested -> trophozoite in colon -> flask-shaped ulcers -> bloody diarrhea -> may spread to liver

Lab Diagnosis:

Stool: Trophozoites with ingested RBCs
Serology: ELISA (liver abscess)

Amoebic Liver Abscess: Right lobe, "anchovy sauce" aspirate, sterile. Diagnosed by serology + USG.

Treatment: Metronidazole + Diloxanide furoate (luminal cyst killer)

⭐ Q13. Diarrheagenic E. coli (Q22)

Type	Mechanism	Disease
ETEC	LT + ST toxin	Traveller's diarrhea
EPEC	Attaches, effacing	Infantile diarrhea
EIEC	Invades mucosa	Dysentery-like
EHEC (O157:H7)	Shiga toxin (Verotoxin)	HUS, bloody diarrhea
EAEC	Aggregative adherence	Persistent diarrhea

⭐ Q14. Leishmaniasis (Q10)

Forms: Kala azar (visceral - L. donovani), Cutaneous (L. tropica), Mucocutaneous (L. braziliensis) Vector: Phlebotomus sandfly (female)

Diagnosis of Kala azar:

Splenic aspirate - most sensitive (95%)
Bone marrow aspirate - safer alternative
LD bodies in macrophages
rK39 antigen rapid test
Aldehyde (Napier's) test - positive in kala azar

Treatment: Miltefosine (oral, 1st line), Amphotericin B, Sodium stibogluconate

⭐ Q15. Herpes Zoster / VZV (Q19, Q38)

Agent: VZV (HHV-3), DNA virus, enveloped Primary infection: Varicella (chickenpox) - centripetal rash, crops of vesicles at different stages Reactivation: Zoster (shingles) - dermatomal, unilateral, painful

Lab: Tzanck smear (multinucleated giant cells), DFA, PCR Treatment: Acyclovir Vaccine: Live attenuated varicella vaccine

⭐ Q16. Cholera (Q37)

Agent: Vibrio cholerae O1/O139, curved Gram -ve rod, darting motility

Pathogenesis: CT (Cholera toxin) -> ADP ribosylation of Gs protein -> ↑cAMP -> hypersecretion Cl-/water -> Rice water diarrhea

Lab: TCBS medium (yellow colonies), hanging drop (shooting star motility), string test positive

Treatment: ORS (primary), Doxycycline (drug of choice)

⭐ Q17. Immunoglobulins - IgM, IgG, IgA (Q33)

IgG: Most abundant (75%), crosses placenta, secondary immune response, opsonization, ADCC. 4 subclasses.

IgM: First to appear (primary response), pentamer (10 binding sites), best agglutinator, classical complement activation, CANNOT cross placenta.

IgA: Secretary immunoglobulin (sIgA), protects mucous membranes (respiratory, GI, GU). Dimeric in secretions with J chain + secretory piece. Most produced overall.

Q18. Leprosy (Q40)

Agent: M. leprae - cannot be cultured in vitro, grown in armadillo footpad

Feature	Tuberculoid (TT)	Lepromatous (LL)
CMI	High	Low
Bacilli	Paucibacillary	Multibacillary
Lepromin test	Positive	Negative
Lesions	Few, well-defined	Multiple, diffuse

Lab: Slit skin smear (ZN stain), Lepromin test (Mitsuda reaction), biopsy

Treatment (MDT):

Paucibacillary: Dapsone + Rifampicin (6 months)
Multibacillary: Rifampicin + Dapsone + Clofazimine (12 months)

Q19. Complement Pathways (Q28)

Classical: Ag-Ab complex (IgG/IgM) -> C1q -> C1r -> C1s -> C4 -> C2 -> C3 -> C5-C9 (MAC)

Alternative: Microbial surfaces (LPS, fungal wall) directly -> C3 -> Factor B, D, Properdin -> C5-C9

Lectin: MBL binds mannose -> MASP1, MASP2 -> C4, C2

Common final pathway: C5b -> C6-C9 = MAC (Membrane Attack Complex) -> cell lysis

Q20. Giardia lamblia (Q13)

Agent: Flagellate protozoa, pear-shaped trophozoite, "falling leaf" motility, 4 nuclei cyst Transmission: Feco-oral, waterborne

Clinical: Malabsorption, steatorrhea, fatty diarrhea (NO blood/mucus)

Diagnosis: Stool (cysts), duodenal aspirate/Enterotest (string test) for trophozoites

Treatment: Metronidazole

Q21. Ascaris lumbricoides (Q16)

Largest intestinal nematode. Transmission: ingesting embryonated eggs.

Life cycle: Egg -> larvae -> intestine -> liver -> heart -> lungs (Loeffler's pneumonia) -> trachea -> swallowed -> intestine -> adult

Complications: Intestinal obstruction, biliary ascariasis, Loeffler's syndrome

Diagnosis: Stool exam (bile-stained mammillated eggs)

Treatment: Albendazole / Mebendazole

Q22. Hookworm - Clinical Case (Q24)

Infective stage: Filariform (L3) larvae - NOT eggs

Mode of infection: Skin penetration (barefoot - ground itch)

Life cycle: Skin -> blood -> lungs -> trachea -> intestine -> blood-sucking adult worms

Complications: Iron deficiency anemia (severe - Hb 5g/dl), hypoproteinemia, Loeffler's pneumonia

Diagnosis: Stool exam (thin-shelled, segmented eggs)

Q23. Leptospirosis (Q14)

Agent: Leptospira interrogans (spirochete), zoonosis (reservoir: rats) Transmission: Contact with water/soil contaminated with animal urine (through skin abrasions)

Weil's disease: Jaundice + renal failure + hemorrhage (severe form)

Lab: Dark field microscopy (blood, week 1), MAT (Microscopic Agglutination Test - gold standard serology), ELISA

Treatment: Penicillin / Doxycycline

Q24. Taenia solium (Q15)

Definitive host: Man (adult tapeworm - taeniasis) Intermediate host: Pig (cysticercus cellulosae in muscles) Cysticercosis in humans: Man accidentally becomes intermediate host (ingests eggs)

Neurocysticercosis: Cysticerci in brain -> seizures, raised ICP. CT: "hole with a dot" (scolex in cyst)

Diagnosis: Stool (proglottids), CT/MRI brain, serology (ELISA)

Treatment: Praziquantel / Albendazole + Steroids (neurocysticercosis)

Q25. Filariasis (Q11)

Agent: Wuchereria bancrofti, Vector: Culex mosquito (night biting)

Life cycle: L3 larvae from bite -> lymphatics -> adult worm -> microfilariae (nocturnal periodicity) in blood

Pathogenesis: Adult worms in lymphatics -> obstruction -> elephantiasis, hydrocele, chyluria

Diagnosis: Midnight blood smear (Giemsa), Knott's concentration, ICT card test, USG (dancing filaria sign)

Treatment: DEC, Ivermectin + Albendazole (MDA program)

Q26. CMI / Immune Response (Q23)

Innate: Non-specific, immediate (skin, mucus, NK cells, complement, phagocytes)

Acquired:

Active Natural: infection; Active Artificial: vaccination
Passive Natural: maternal Ab/colostrum; Passive Artificial: IVIG, antitoxin

CMI:

CD4 Th1 -> IL-2, IFN-γ -> macrophage activation -> intracellular pathogens (TB, fungi, viruses)
CD8 CTL -> kill virus-infected cells

Assessment of CMI: Lymphocyte proliferation test, Delayed hypersensitivity skin test (Mantoux)

Q27. MRSA (Q31)

mecA gene -> encodes PBP2a -> low affinity for ALL beta-lactams
Resistant to: ALL penicillins, cephalosporins, carbapenems
HA-MRSA (hospital) vs CA-MRSA (community)
Treatment: Vancomycin (DOC), Linezolid, Daptomycin
Detection: Cefoxitin disc diffusion, mecA PCR

Q28. Dermatophytes (Q25)

Organisms: Trichophyton, Microsporum, Epidermophyton

Types: Tinea capitis (scalp), Tinea corporis (body), Tinea pedis (athlete's foot), Tinea unguium (nail), Tinea cruris (groin)

Diagnosis: KOH mount (branching hyphae + arthrospores), Wood's lamp (green fluorescence - Microsporum), Culture on SDA

Treatment: Topical antifungals (clotrimazole), Terbinafine, Griseofulvin (nails/scalp)

Q29. Gas Gangrene (Q45)

Agent: Clostridium perfringens type A, Gram +ve anaerobic rod, spore-forming Alpha toxin (lecithinase/phospholipase C): Main virulence factor

Features: Gas in tissue, sweet smell, crepitus, myonecrosis, wound infection

Diagnosis: Gram stain (Gram +ve rods), X-ray (gas in tissue), anaerobic culture

Treatment: Surgical debridement (MOST important) + high dose Penicillin + Hyperbaric O2

PAPER 2 - HIGH YIELD ANSWERS

⭐ Q1. Tuberculosis (Q12)

Agent: M. tuberculosis, acid-fast bacillus (ZN stain - red on blue), slow grower

Pathogenesis: Droplet transmission -> primary complex (Ghon focus + hilar lymphadenopathy) -> healed / progressive / post-primary TB

Lab Diagnosis:

ZN stain: AFB red on blue background
Auramine rhodamine fluorescence: more sensitive
Culture: LJ medium (6-8 weeks), BACTEC MGIT (2 weeks) - gold standard
GeneXpert MTB/RIF: Detects TB + Rifampicin resistance in 2 hours - MOST IMPORTANT
Line Probe Assay (LPA): MTBDRplus detects rpoB (R), inhA/katG (H) mutations
Tuberculin Skin Test (Mantoux): PPD 5TU intradermal, read at 48-72 hrs, ≥10 mm = positive

Treatment (RIPE):

Intensive phase (2 months): Rifampicin + Isoniazid + Pyrazinamide + Ethambutol
Continuation phase (4 months): Rifampicin + Isoniazid
MDR-TB: Resistant to R + H. XDR-TB: MDR + Fluoroquinolone + injectable drug resistance

Atypical Mycobacteria (NTM): MAC, M. kansasii, M. fortuitum, M. marinum ("fish tank granuloma"), M. ulcerans (Buruli ulcer)

⭐ Q2. Bacterial Meningitis (Q8)

Organisms by age:

Neonates: Group B Strep, E. coli, Listeria
Children: N. meningitidis, H. influenzae
Adults: N. meningitidis, S. pneumoniae
Elderly: S. pneumoniae, Listeria

CSF Analysis:

Parameter	Bacterial	Viral	TB	Fungal
Appearance	Turbid	Clear	Fibrin web	Clear
Cells	>1000 PMN	<500 Lymph	100-500 Lymph	Lymph
Protein	↑↑	Normal/↑	↑↑	↑
Glucose	↓↓	Normal	↓	↓

Meningococcal Meningitis: N. meningitidis, Gram -ve diplococci. Waterhouse-Friderichsen syndrome (bilateral adrenal hemorrhage, purpuric rash, shock)

Cryptococcal Meningitis: C. neoformans, India ink (capsule as halo), latex agglutination, mainly in HIV. Treatment: Amphotericin B + Flucytosine -> Fluconazole

TB Meningitis: Cobweb clot CSF, lymphocytes, high protein, low glucose, ADA elevated

⭐ Q3. Syphilis (Q11)

Agent: Treponema pallidum (spirochete), not culturable

Stages:

Primary: Painless chancre (single, indurated, clean base)
Secondary: Condylomata lata, maculopapular rash on palms & soles, highly infectious
Latent: Serology positive, no symptoms
Tertiary: Gumma, cardiovascular syphilis (aortitis), neurosyphilis

Lab Diagnosis:

Direct: Dark field microscopy (primary/secondary lesions)
Non-treponemal (screening + quantitative): VDRL, RPR
Treponemal (confirmatory): TPHA, FTA-ABS, TPPA (remain positive for life)

RPR Test: Cardiolipin antigen + charcoal particles. Flocculation test. Biological false positive: SLE, pregnancy, malaria

Treatment: Benzathine Penicillin G (DOC for all stages)

⭐ Q4. Rabies (Q3)

Agent: Lyssavirus (Rhabdovirus), ss RNA, bullet-shaped Transmission: Bite of infected animal (dog most common)

Pathogenesis: Virus enters peripheral nerve -> travels centripetally to CNS -> replicates -> spreads to salivary glands

Pathognomonic: Negri bodies (eosinophilic cytoplasmic inclusions in Purkinje cells of cerebellum / hippocampus)

Lab Diagnosis:

Post-mortem: Negri bodies (Sellers stain), FAT (most sensitive)
Antemortem: Skin biopsy (nape of neck), saliva, CSF - DFA/PCR

Post Exposure Prophylaxis (PEP):

Wound washing with soap + water for 15 min (MOST important step)
RIG (HRIG 20 IU/kg) - infiltrate wound if not previously vaccinated
Vaccine: 4 doses on days 0, 3, 7, 14 (PCEC or PVRV)

⭐ Q5. Streptococcus pyogenes (Q7)

Group A Strep (GAS), beta-hemolytic

Virulence factors: M protein (main, anti-phagocytic), Streptolysin S & O (SLO), Streptokinase, Hyaluronidase, Erythrogenic toxin (scarlet fever)

Diseases: Pharyngitis, Impetigo, Scarlet fever, Erysipelas, Necrotizing fasciitis

Post-streptococcal complications:

Rheumatic fever (after pharyngitis only): Carditis, arthritis, Sydenham's chorea, erythema marginatum, subcutaneous nodules
PSGN (after pharyngitis or skin infection): Hematuria, hypertension, edema

Lab: Blood agar (beta hemolysis), Bacitracin sensitive, ASO titer (retrospective)

⭐ Q6. Diphtheria (Q2)

Agent: Corynebacterium diphtheriae, Gram +ve rod, Chinese letter arrangement, metachromatic granules (Babes-Ernst)

Toxin: Exotoxin (coded by beta phage) - ADP-ribosylation of EF-2 (elongation factor 2) -> inhibits protein synthesis -> myocarditis, neuropathy

Disease: Grayish-white pseudomembrane (bleeds on removal), bull neck, myocarditis, palatal palsy

Lab:

Loeffler's serum slope (metachromatic granules)
Tellurite agar (black/gray colonies)
Elek's gel precipitation test (toxigenicity)

Schick Test: Positive = susceptible (no antitoxin). Negative = immune.

Treatment: Diphtheria antitoxin (DAT) + Penicillin/Erythromycin

⭐ Q7. Polio Virus (Q4)

Agent: Picornavirus/Enterovirus, 3 serotypes (P1, P2, P3), feco-oral transmission

Pathogenesis: Oropharynx -> GI -> viremia -> anterior horn cells -> flaccid paralysis (LMN)

OPV vs IPV:

Feature	OPV (Sabin)	IPV (Salk)
Type	Live attenuated	Killed
Route	Oral	Injection
Immunity	Mucosal IgA + Humoral	Humoral only
Herd immunity	Yes	No
Risk	VAPP (1:2.4 million)	None

⭐ Q8. Influenza / Swine Flu (Q5)

Agent: Orthomyxovirus, ss RNA, 8 segments Key antigens: HA (hemagglutinin - attachment), NA (neuraminidase - release)

Antigenic Shift: Major change - reassortment -> Pandemic Antigenic Drift: Minor change - point mutations -> Seasonal epidemics

H1N1:

Diagnosis: RT-PCR (nasopharyngeal swab)
Treatment: Oseltamivir (Tamiflu), Zanamivir
Prevention: Annual influenza vaccine

⭐ Q9. Clostridium tetani (Q14)

Agent: Gram +ve anaerobe, spore-forming. Drumstick appearance (terminal spore).

Tetanospasmin: Blocks GABA and Glycine at Renshaw cells -> loss of inhibition -> spastic paralysis

Features: Trismus (lockjaw), risus sardonicus, opisthotonos

Treatment: HTIG (Human Tetanus Immunoglobulin) + Penicillin/Metronidazole + Diazepam + wound debridement

Prevention: TT vaccine (DTP schedule). Booster every 10 years.

⭐ Q10. Gonorrhea & STIs (Paper 2, Q1)

Agent: Neisseria gonorrhoeae, Gram -ve diplococci (intracellular in PMNs - pathognomonic)

Other STI organisms: T. pallidum (syphilis), C. trachomatis (NGU/LGV), HSV-2, HPV, T. vaginalis, H. ducreyi (chancroid)

Complications: PID, Fitz-Hugh-Curtis syndrome (perihepatitis), ophthalmia neonatorum, DGI

Lab: Gram stain (intracellular diplococci), Culture on Thayer-Martin medium, NAAT (most sensitive)

Treatment: Ceftriaxone + Azithromycin (dual therapy)

⭐ Q11. Echinococcus granulosus (Q9)

Definitive host: Dog. Intermediate host: Sheep, cattle, humans (accidental) Transmission: Ingesting eggs from dog feces Site: Liver (most common), then Lung

Hydatid cyst structure: Pericyst (host) + ectocyst (laminated) + endocyst (germinal) + brood capsules + scolices + hydatid sand

Diagnosis: USG (best), CT, Casoni test (intradermal), serology (ELISA), eosinophilia

Treatment: PAIR (Puncture, Aspiration, Injection hypertonic saline, Re-aspiration) + Albendazole. Surgery if needed. NEVER blindly aspirate - risk of anaphylaxis.

Q12. Plague (Q13)

Agent: Yersinia pestis, Gram -ve bipolar "safety pin" staining (Wayson stain), zoonosis (rats) Vector: Rat flea (Xenopsylla cheopis)

Clinical Types:

Bubonic: Bubo (painful lymphadenopathy in groin/axilla)
Pneumonic: Most dangerous, person-to-person transmission, ~100% fatal untreated
Septicemic: DIC, hemorrhage

Treatment: Streptomycin (DOC), Doxycycline, Ciprofloxacin

Q13. Aspergillosis (Q23)

Agent: Aspergillus fumigatus (most common). Septate hyphae with 45° (acute angle) branching.

Forms:

ABPA: Asthma + eosinophilia + fleeting shadows on X-ray
Aspergilloma: Fungal ball in pre-existing cavity (Monod sign / air crescent sign)
Invasive Aspergillosis: Immunocompromised (neutropenic) - most serious. CT: halo sign
Otomycosis: External ear

Diagnosis: Culture (SDA), Galactomannan antigen, Beta-glucan, CT chest, biopsy

Treatment: Voriconazole (DOC), Amphotericin B

Q14. COVID-19 (Q15)

Agent: SARS-CoV-2, Betacoronavirus, +ss RNA, enveloped

Pathogenesis: Spike protein binds ACE2 on type II pneumocytes -> viral replication -> cytokine storm -> ARDS, hypercoagulability, multiorgan failure

Lab: RT-PCR (gold standard), Rapid Antigen Test (screening), Antibody (past infection/vaccine)

Treatment: Remdesivir, Dexamethasone (severe/hypoxemic), Nirmatrelvir-ritonavir (Paxlovid)

Q15. Chlamydia / LGV (Q20)

C. trachomatis - obligate intracellular, no cell wall

Serotypes A, B, Ba: Trachoma (leading cause of preventable blindness)
Serotypes D-K: NGU, PID, neonatal conjunctivitis
Serotypes L1, L2, L3: LGV

LGV stages: Painless papule -> painful inguinal bubo -> groove sign (lymphadenopathy above + below inguinal ligament)

Diagnosis: NAAT, serology (CFT) Treatment: Doxycycline 100 mg BD x 21 days

Q16. Toxoplasma gondii (Q32)

Definitive host: Cat (sexual cycle). Intermediate host: All warm-blooded animals + humans

Transmission: Oocysts (cat feces), tissue cysts (undercooked meat), transplacental

Congenital Toxoplasmosis Tetrad:

Hydrocephalus
Chorioretinitis
Intracranial calcifications
Psychomotor retardation

In HIV: Ring-enhancing lesions on CT brain

Diagnosis: Serology (IgM = acute), PCR (amniotic fluid), CT brain Treatment: Pyrimethamine + Sulfadiazine + Folinic acid

Q17. Atypical Pneumonia / Mycoplasma (Q35)

Agent: Mycoplasma pneumoniae - smallest free-living organism, NO cell wall -> NOT sensitive to beta-lactams

Features: "Walking pneumonia" - mild, insidious, community-acquired in young adults

Lab:

Cold agglutinins (IgM against RBC I antigen) - non-specific
Culture on Eaton's medium (requires cholesterol)
Serology (CFT, ELISA), PCR

Treatment: Macrolides (Azithromycin), Doxycycline, Fluoroquinolones

Q18. Brucellosis (Q45)

Agent: Brucella - Gram -ve coccobacilli, zoonosis

B. abortus (cattle), B. melitensis (goats - most virulent), B. suis (pigs)

Transmission: Unpasteurized milk/cheese, direct contact with infected animals

Lab Diagnosis:

Blood culture: Castaneda's medium (most definitive)
Serology: SAT titer ≥1:160 significant, Rose Bengal test (screening), ELISA

Treatment: Doxycycline + Rifampicin (6 weeks) - combination is essential to prevent relapse

Q19. Trichomonas vaginalis (Q33)

Agent: Flagellate protozoa, ONLY trophozoite form (no cyst), pear-shaped, 4 anterior flagella

Clinical: Frothy greenish-yellow foul-smelling vaginal discharge, strawberry cervix, dysuria

Lab: Wet mount (saline) - pear-shaped motile trophozoites, culture (Diamond's medium), NAAT

Treatment: Metronidazole 2g single dose - treat BOTH partners

Q20. Pertussis / Whooping Cough (Q50)

Agent: Bordetella pertussis, Gram -ve coccobacillus

Pertussis toxin: ADP-ribosylation of Gi protein -> lymphocytosis

Stages:

Catarrhal (most contagious): cold-like symptoms
Paroxysmal: Whooping cough (whoop on inspiration), post-tussive vomiting
Convalescent: gradual recovery

Lab: Pernasal swab/NPA -> Bordet-Gengou medium (potato blood agar), PCR

Treatment: Azithromycin (or Erythromycin) Vaccine: DTP/DTaP

Q21. Naegleria fowleri (Q29)

Primary Amoebic Meningoencephalitis (PAM)

Transmission: Swimming in warm freshwater (enters via cribriform plate)

Unique feature: Exists in 3 forms: Amoeboid, Flagellate (distinguishing), Cyst

Clinical: Fulminant meningoencephalitis, almost 100% fatal

Diagnosis: CSF - motile trophozoites, culture, CT brain

Treatment: Amphotericin B (rarely successful), Miltefosine (newer option)

Q22. Slow Viral Infections / Prions (Q24, Q42)

Disease	Agent	Feature
Kuru	Prion	Cannibalism (Fore tribe), cerebellar ataxia
CJD	Prion	Rapidly progressive dementia, myoclonus
SSPE	Measles virus	Progressive dementia in children after measles
PML	JC virus	Immunocompromised patients

Prions: PrPc (normal) -> PrPsc (misfolded, disease-causing). No nucleic acid. Resistant to heat, UV, formalin.

Q23. Oncogenic Viruses (Q36)

Virus	Associated Cancer
HPV 16, 18	Cervical carcinoma, oropharyngeal
EBV	Burkitt lymphoma, NPC, Hodgkin's
HBV + HCV	Hepatocellular carcinoma
HTLV-1	Adult T-cell leukemia/lymphoma
HHV-8 (KSHV)	Kaposi sarcoma
MCPyV	Merkel cell carcinoma

Q24. Japanese Encephalitis (Q40)

Agent: Flavivirus (RNA). Vector: Culex tritaeniorhynchus. Reservoir: Pigs + Wading birds

Clinical: Encephalitis, seizures, Parkinsonian features, mask-like facies

Lab: IgM capture ELISA (CSF/serum), RT-PCR, CSF - lymphocytic pleocytosis

Vaccine: SA14-14-2 (live attenuated), IXIARO (inactivated)

Q25. Viral Hemorrhagic Fevers (Q38)

VHF	Agent	Vector/Reservoir	Treatment
Ebola	Filovirus	Fruit bats, contact	Zmapp (MAb)
Lassa	Arenavirus	Rodents	Ribavirin
CCHF	Bunyavirus	Hyalomma tick	Ribavirin
Yellow fever	Flavivirus	Aedes mosquito	Supportive
Dengue HF	Flavivirus	Aedes aegypti	Supportive

Q26. Mumps (Q49)

Agent: Paramyxovirus, ss RNA Features: Bilateral parotitis (painful), Orchitis (post-pubertal males - infertility risk), Meningitis, Pancreatitis

Lab: Serology (IgM ELISA), RT-PCR Treatment: Supportive Vaccine: MMR (live attenuated)

Q27. Congenital Rubella Syndrome (Q47)

Gregg's Triad:

Cataracts
Congenital heart defects (PDA, pulmonary stenosis)
Sensorineural deafness

Risk: Highest in first trimester (>80%)

Other features: Blueberry muffin rash, microcephaly, IUGR

Diagnosis: IgM in baby, virus isolation from urine, PCR

Prevention: MMR vaccine pre-conception. CONTRAINDICATED in pregnancy.

Q28. Zygomycosis / Mucormycosis (Q46)

Agents: Rhizopus (most common), Mucor, Absidia

Morphology: Broad, NON-septate hyphae with wide angle (90°) branching - distinguishes from Aspergillus (which is septate, 45°)

Predisposing factors: Diabetes (DKA - most common), neutropenia, deferoxamine therapy

Forms: Rhinocerebral (most common), Pulmonary, Cutaneous

Diagnosis: KOH mount/biopsy (wide non-septate hyphae), culture on SDA

Treatment: Liposomal Amphotericin B + aggressive surgical debridement

AETCOM KEY POINTS (Both Papers)

Disclosing sensitive results (HIV/HBV/HCV):

Private setting, face-to-face (never over phone)
Maintain strict confidentiality
Simple, non-technical language
Show empathy, non-judgmental attitude
Explain disease, treatment, prognosis
Counseling: partner notification, safe sex, avoid blood donation
Follow NACO/hospital guidelines

Informed Consent (surgery):

Nature of diagnosis
Nature of surgery + alternatives
Risks and benefits
Right to refuse
Post-operative care
Use vernacular language if needed

5 Moments of Hand Hygiene (WHO):

Before patient contact
Before aseptic procedure
After body fluid exposure
After patient contact
After contact with patient surroundings

Study Priority: Paper 1: HIV > Malaria > Typhoid > Hepatitis > Hypersensitivity > Sterilization > Drug resistance > ELISA > Cholera > E. histolytica

Paper 2: TB > Meningitis > Syphilis > Rabies > Gonorrhea > Diphtheria > Polio > Tetanus > Influenza > Echinococcus

Can you name these questions under their respective chapter names only question is enough no need giving whole answer again

Here are all questions from both papers organized under their chapter names:

PAPER 1

Immunology

Autoimmunity, Mechanisms, SLE, Autoimmune diseases classification
Antigen-Antibody Reactions, Agglutination, Monoclonal Antibodies
ELISA
Hypersensitivity Reactions (Type I, II, III, IV), Shwartzman Reaction
Define Immune Response, Cell Mediated Immunity, Active/Passive/Innate/Acquired Immunity
Alternative & Classical Complement Pathways
Structure and Functions of IgM, IgA, IgG
Allograft Reaction, Graft Versus Host Disease

General Microbiology

Sterilization, Moist Heat, Autoclave, Disinfectants (High level, Gaseous, Chemical)
Enrichment Media, Selective Media
Anaerobic Culture Methods
Mechanism of Drug Resistance, Genetic Mechanisms, Antimicrobial Resistance
MRSA (Methicillin Resistant Staphylococcus Aureus)
Blood Culture Methods for Infective Endocarditis
Moments of Hand Hygiene
Standard / Universal Precautions
Louis Pasteur, Robert Koch

Bacteriology

Enteric (Typhoid) Fever, Widal Test, Drug Resistance, Vaccine
Diarrheagenic E. coli
Cholera
Leptospirosis
Bacillary Dysentery (Pathogenesis + Lab Diagnosis)
Gas Gangrene
Helicobacter Pylori
Campylobacter Infections
Leprosy, Laboratory Diagnosis
Actinomycosis, Mycetoma
Toxic Shock Syndrome
Mechanisms of Bacterial Pathogenesis
Food poisoning case (Bacillus cereus - Chinese fried rice scenario)

Virology

HIV/AIDS, Western Blot, NACO, ART, PEP, Opportunistic Fungal Infections
Dengue, Pathogenesis, Clinical, Investigations, Treatment
Hepatitis Viruses, Morphology, Serological Markers, Prophylaxis of HBV, Hepatitis C
Herpes Zoster
Varicella Zoster Virus
Viral Gastroenteritis
Lab Diagnosis of Viral Infections

Parasitology

Malaria, Life Cycle, Pathogenesis, Lab Diagnosis, Vaccine, Cerebral Malaria
Leishmaniasis, Life Cycle, Lab Diagnosis, Treatment
Bancroftian Filariasis, Lymphatic Filariasis
Entamoeba histolytica
Giardia lamblia
Taenia Solium
Ascaris lumbricoides
Hookworm (clinical case - pallor, Hb 5g/dl)
Larva Migrans
Enterobius Vermicularis
Amoebic Liver Abscess
Cysticercus Cellulosae

Mycology

Dermatophytes / Dermatophytoses
Lab Diagnosis of Fungal Infections

PAPER 2

Bacteriology

Neisseria Gonorrhoeae, STI organisms, Pathogenesis, Diagnosis, Management
Diphtheria
Streptococcus Pyogenes
Bacterial Meningitis, Lab Diagnosis, Meningococcal Meningitis, Tuberculous Meningitis
Tuberculosis, Molecular Methods, Pathogenesis, Treatment, Tuberculin Skin Test, Atypical Mycobacteria
Plague, Clinical Types
Clostridium Tetani, Tetanus Prevention
Complications of Post-Streptococcal Infection
Satellitism
Anaerobic Vaginosis
Bacillus anthracis, Cutaneous Anthrax, Pulmonary Anthrax
Urinary Tract Infections, Lab Diagnosis
Acute Pyelonephritis - Causative Organisms + Pathogenesis
Yersinia pestis
Chancroid
Lymphogranuloma Venereum
Non-Gonococcal Urethritis
Borrelia Vincenti
Brucellosis, Lab Diagnosis
Tularemia
Pertussis (Whooping Cough)
Elek's Gel Precipitation Test
Atypical Pneumonia (Mycoplasma Pneumonia)
Infection Control Policy

Virology

Rabies, PEP, Morphology, Pathogenesis, Lab Diagnosis
Picornavirus (Polio), OPV vs IPV
Myxovirus, Influenza, Swine Flu, H1N1 Diagnosis & Prophylaxis
Covid-19, Pathogenesis
Slow Viral Infections
Oncogenic Viruses
Viral Hemorrhagic Fevers
Japanese B Encephalitis
Congenital Rubella Syndrome
Mumps
Prions
Rapid Plasma Reagin (RPR) Test

Parasitology

Taenia Solium
Classify Cestodes, Echinococcus granulosus - Life Cycle, Pathogenesis, Lab Diagnosis
Cerebral Malaria
Neurocysticercosis
Naegleria fowleri
Primary Amoebic Encephalitis
Morphology and Life Cycle of Toxoplasma gondii
Trichomonas vaginalis
Paragonimiasis

Mycology

Pneumocystis Pneumonia (PCP)
Aspergillosis
Histoplasmosis
Zygomycosis, Opportunistic Mycoses

STIs / Genitourinary

Classify STDs, Syphilis, Pathogenesis, Lab Diagnosis, Primary & Secondary Syphilis
Lymphogranuloma Venereum
Chancroid
Non-Gonococcal Urethritis
Anaerobic Vaginosis
Trichomonas vaginalis

Note: A few topics appear in both papers (Taenia solium, Cerebral malaria) - study them once thoroughly and you're covered for both!

Why some chapters were in both paper I and 2

Great question! Here's why:

NTRUHS Paper 1 vs Paper 2 - How They're Divided

NTRUHS (and most Indian medical universities) split Microbiology into two separate exam papers based on broad subject divisions, not strictly by chapter. Here's the typical logic:

Paper 1 focuses on:

General Microbiology (sterilization, culture media, lab methods)
Immunology (hypersensitivity, vaccines, antibodies)
Parasitology (most of it)
Some Bacteriology (GI pathogens mostly - Salmonella, Vibrio, E. coli)
Some Virology (HIV, Dengue, Hepatitis)

Paper 2 focuses on:

Systemic Bacteriology (organ-system based - respiratory, STIs, CNS, urinary)
Mycology (fungi)
More Virology (Rabies, Polio, Influenza, Slow viruses)
STIs as a group

Why Overlap Happens

Parasitology is huge - Taenia solium, Cerebral malaria naturally spill into both papers depending on the examiner's focus (general parasite in P1, CNS complication in P2)
Examiners set questions independently for each paper - there's no strict "this topic only in P1" rule
Topics like Meningitis are partly bacteriology (P2) and partly lab diagnosis/immunology (P1)
These are "Super-50" prep sheets - compiled by coaching institutes covering ALL likely questions across both papers, so some topics are listed in both intentionally to make sure you don't miss them

Bottom line: Don't worry about which paper a topic "belongs to" - just study the topic once and you're prepared for either paper!

This is a shared conversation. Sign in to Orris to start your own chat.